Results 1 to 10 of about 43,843 (242)
Excitatory Amino-Acid Antagonists and Their Possible Clinical Application
CHIMIA, 1991 A brief review of the pharmacology of some excitatory amino-acid receptor antagonists, active at the N-methyl-D-aspartate receptor subtype, and prospects of their possible therapeutic indication are given.
Peter Frey
doaj +6 more sources
Excitatory amino acid antagonists for acute stroke [PDF]
Cochrane Database of Systematic Reviews, 2003 Focal cerebral ischaemia causes release of excitatory amino acid (EAA) neurotransmitters, principally glutamate, with resultant over-stimulation of EAA receptors and downstream pathways. Excess glutamate release is a pivotal event in the evolution of irreversible ischaemic damage in animal models of ischaemia, and drugs that modulate glutamate action ...
Keith W. Muir, Kennedy R. Lees
openalex +4 more sources
Excitatory amino acid antagonists induce a phencyclidine-like catalepsy in pigeons: Structure-activity studies☆ [PDF]
, 1987 The excitatory amino acid antagonists -2-amino-5-phosphonovalerate (-AP5), its isomers -(-)-AP5 and -(+)-AP5, -2-amino-4-phosphonobutyrate (AP4), -2-amino-7-phosphonoheptanoate (AP7), [beta]--aspartylaminomethylphosphonic acid (ASP-AMP), cis-2,3 ...
Wouter Koek +4 more
openalex +2 more sources
Effects of excitatory amino acid antagonists on evoked and spontaneous excitatory potentials in guinea‐pig hippocampus. [PDF]
The Journal of Physiology, 1986 Evoked and spontaneous excitatory post‐synaptic potentials (e.p.s.p.s) at the mossy fibre input to CA3 pyramidal neurones were recorded intracellularly in slices from the guinea‐pig hippocampus. The effects of several amino acid antagonists on these responses were examined. L‐2‐amino‐4‐phosphonobutyrate (L‐AP4), L‐serine‐O‐phosphate (L‐SOP), kynurenate,
Carl W. Cotman +3 more
openalex +4 more sources
The Role of Glutamate Receptors in Epilepsy
Biomedicines, 2023 Glutamate is an essential excitatory neurotransmitter in the central nervous system, playing an indispensable role in neuronal development and memory formation. The dysregulation of glutamate receptors and the glutamatergic system is involved in numerous
Tsang-Shan Chen +3 more
doaj +1 more source
Frontiers in Cell and Developmental Biology, 2023 Ionotropic glutamate receptors (iGluRs) mediate the majority of excitatory neurotransmission and are implicated in various neurological disorders. In this review, we discuss the role of the two fastest iGluRs subtypes, namely, α-amino-3-hydroxy-5-methyl ...
Marina N. Vukolova +5 more
doaj +1 more source
Neuroprotection, excitotoxicicity and nmda antagonists [PDF]
Arquivos de Neuro-Psiquiatria, 2000 PURPOSE: To analyze the main aspects of neuroprotection and excitotoxicity. DISCUSSION: This is a significant theory on the pathophysiology of cerebral ischemia; it is based on the release of excitatory aminoacid (EAA), mainly glutamate.
RUBENS JOSÉ GAGLIARDI
doaj +1 more source
The effects of angiotensin II and angiotensin-(1-7) in the rostral ventrolateral medulla of rats on stress-induced hypertension. [PDF]
PLoS ONE, 2013 We have shown that angiotensin II (Ang II) and angiotensin-(1-7) [Ang-(1-7)] increased arterial blood pressure (BP) via glutamate release when microinjected into the rostral ventrolateral medulla (RVLM) in normotensive rats (control).
Dongshu Du +9 more
doaj +1 more source
Biomolecules, 2022 L-Glutamic acid is the main excitatory neurotransmitter in the central nervous system (CNS). Its associated receptors localized on neuronal and non-neuronal cells mediate rapid excitatory synaptic transmission in the CNS and regulate a wide range of ...
Elena A. Golubeva +3 more
doaj +1 more source
Biomedicines, 2023 Status epilepticus (SE) is a neurological emergency with a high mortality rate. When compared to chronic epilepsy, it is distinguished by the durability of seizures and frequent resistance to benzodiazepine (BZD).
Tzu-Hsin Huang +3 more
doaj +1 more source